1. Kokudo N, Takemura N, Ito K, Mihara F. 2020; The history of liver surgery: achievements over the past 50 years. Ann Gastroenterol Surg. 4:109–117. DOI:
10.1002/ags3.12322. PMID:
32258975. PMCID:
PMC7105847.
2. Deng G, Li H, Jia GQ, Fang D, Tang YY, Xie J, et al. 2019; Parenchymal-sparing versus extended hepatectomy for colorectal liver metastases: a systematic review and meta-analysis. Cancer Med. 8:6165–6175. DOI:
10.1002/cam4.2515. PMID:
31464101. PMCID:
PMC6797569.
3. Makdissi FF, Kruger JAP, Jeismann VB, Herman P. 2021; Feasibility of right upper transversal hepatectomy in the absence of an inferior right hepatic vein: new insights regarding this complex procedure. Case Rep Surg. 2021:6668269. DOI:
10.1155/2021/6668269. PMID:
33747594. PMCID:
PMC7960046.
5. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. 2002; Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 8:233–240. DOI:
10.1053/jlts.2002.31654. PMID:
11910568.
6. Bernts LHP, Neijenhuis MK, Edwards ME, Sloan JA, Fischer J, Smoot RL, et al. 2020; Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. Surgery. 168:25–32. DOI:
10.1016/j.surg.2020.02.014. PMID:
32402542. PMCID:
PMC7347464.
7. Chebib FT, Harmon A, Irazabal Mira MV, Jung YS, Edwards ME, Hogan MC, et al. 2016; Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease. J Am Coll Surg. 223:118–126.e1. DOI:
10.1016/j.jamcollsurg.2015.12.051. PMID:
27016902. PMCID:
PMC4967356.
8. Chansangrat J, Keeratibharat N. 2021; Portal vein embolization: rationale, techniques, outcomes and novel strategies. Hepat Oncol. 8:HEP42. DOI:
10.2217/hep-2021-0006. PMID:
34765107. PMCID:
PMC8577518.
9. Gandhi CR, Murase N, Subbotin VM, Uemura T, Nalesnik M, Demetris AJ, et al. 2002; Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol. 37:340–348. DOI:
10.1016/S0168-8278(02)00165-4. PMID:
12175629.
11. European Association for the Study of the Liver. 2022; EASL Clinical Practice Guidelines on the management of cystic liver diseases. J Hepatol. 77:1083–1108. DOI:
10.1016/j.jhep.2022.06.002. PMID:
35728731.
12. Wurster EF, Tenckhoff S, Probst P, Jensen K, Dolger E, Knebel P, et al. 2017; A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases. HPB (Oxford). 19:491–497. DOI:
10.1016/j.hpb.2017.02.440. PMID:
28347640.
13. Bartsch F, Eberhard J, Ruckert F, Schmelzle M, Lehwald-Tywuschik N, Fichtner-Feigl S, et al. 2021; Repeated resection for recurrent intrahepatic cholangiocarcinoma: a retrospective German multicentre study. Liver Int. 41:180–191. DOI:
10.1111/liv.14682. PMID:
32997886.
14. Midorikawa Y, Takayama T, Moriguchi M, Yagi R, Yamagishi S, Nakayama H, et al. 2020; Liver resection versus embolization for recurrent hepatocellular carcinoma. World J Surg. 44:232–240. DOI:
10.1007/s00268-019-05225-2. PMID:
31605170.
15. Urbani L, Roffi N, Signori S, Balestri R, Colombatto P, Licitra G, et al. 2022; Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection. Langenbecks Arch Surg. 407:1741–1750. DOI:
10.1007/s00423-021-02409-0. PMID:
35028737.
16. Panaro F, Al-Farai A, Cubisino A, Testa G. 2022; Parenchyma sparing hepatic resection with right hepatic vein reconstruction: lesson learned from living donor liver transplantation. J Gastrointest Surg. 26:1963–1966. DOI:
10.1007/s11605-022-05314-z. PMID:
35411499.